Estimated risk of pheochromocytoma recurrence after adrenal-sparing surgery in patients with multiple endocrine neoplasia type 2A

Archives of Surgery

Volumn 141, Issue 12, 2006, Pages 1199-1205

  Asari, Reza ^a,b   Scheuba, Christian ^a   Kaczirek, Klaus ^a   Niederle, Bruno ^b  

^a Section of Endocrine Surgery   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CATECHOLAMINE; DOPAMINE; NORADRENALIN; PROTEIN RET;

ADRENALECTOMY; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RISK FACTOR; SIPPLE SYNDROME; TUMOR RECURRENCE; URINALYSIS; URINE LEVEL;

ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, MULTIPLE PRIMARY; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 33845626189     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.12.1199     Document Type: Article

References (32)

1. Evans DB, Lee JE, Merrell RC, Hickey RC. Adrenal medullary disease in multiple endocrine neoplasia type 2: appropriate management. Endocrinol Metab Clin North Am. 1994;23:167-176.
2. Lips KJ, Van der Sluys Veer J, Struyvenberg A, et al. Bilateral occurrence of pheochromocytoma in patients with the multiple endocrine neoplasia syndrome type 2A (Sipple's syndrome). Am J Med. 1981;70:1051-1060.
3. van Heerden JA, Sizemore GW, Carney JA, et al. Surgical management of the adrenal glands in the multiple endocrine neoplasia type II syndrome. World J Surg. 1984;8:612-621.
4. Neumann HP, Reincke M, Bender BU, Elsner R, Janetschek G. Preserved adrenocortical function after laparoscopic bilateral adrenal sparing surgery for hereditary pheochromocytoma. J Clin Endocrinol Metab. 1999;84:2608-2610.
5. Fink M, Weinhusel A, Niederle B, Haas OA. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. Study Group Multiple Endocrine Neoplasia Austria (SMENA). Int J Cancer. 1996;69:312-316.
6. Wilson RA, Ibanez ML. A comparative study of 14 cases of familial and nonfamilial pheochromocytomas. Hum Pathol. 1978;9:181-188.
7. Tibblin S, Dymling JF, Ingemansson S, Telenius-Berg M. Unilateral versus bilateral adrenalectomy in multiple endocrine neoplasia IIA. World J Surg. 1983;7:201-208.
8. Shapiro B, Copp JE, Sisson JC, et al. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med. 1985;26:576-585.
9. Jansson S, Tisell LE, Fjalling M, et al. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers. Surgery. 1988;103:11-18.
10. Oishi S, Sasaki M, Yamauchi J, Umeda T, Sato T. Analysis of eight Sipple's syndrome patients and review of eighty-two cases from the Japanese literature. Jpn J Clin Oncol. 1990;20:392-406.
11. Casanova S, Rosenberg-Bourgin M, Farkas D, et al. Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases. Clin Endocrinol (Oxf ). 1993;38:531-537.
12. Lairmore TC, Ball DW, Baylin SB, Wells SA Jr. Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg. 1993;217:595-603.
13. Goretzki PES, Dotzenrath D, Röher C. Surgery for pheochromocytoma in MEN II patients: a radical versus a limited approach. Acta Chir Aust. 1996;28:296-301.
14. Edstrom E, Grondal S, Norstrom F, et al. Long term experience after subtotal adrenalectomy for multiple endocrine neoplasia type IIa. Eur J Surg. 1999;165:431-435.
15. Neumann HP, Bender BU, Reincke M, et al. Adrenal-sparing surgery for phaeochromocytoma. Br J Surg. 1999;86:94-97.
16. de Graaf JSD, Zwierstra RPF. Complications after bilateral adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2: a plea to conserve adrenal function. Eur J Surg. 1999;165:843-846.
17. Inabnet WB, Caragliano P, Pertsemlidis D. Pheochromocytoma: inherited associations, bilaterality, and cortex preservation. Surgery. 2000;128:1007-1011.
18. Nguyen L, Niccoli-Sire P, Caron P, et al. Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study. Eur J Endocrinol. 2001;144:37-44.
19. Takami H, Ikeda Y, Takayama J, et al. Adrenal-sparing adrenalectomy in hereditary bilateral phaeochromocytoma. ANZ J Surg. 2001;71:623-624.
20. Brunt LM, Lairmore TC, Doherty GM, et al. Adrenalectomy for familial pheochromocytoma in the laparoscopic era. Ann Surg. 2002;235:713-721.
21. Walz MK, Peitgen K, Neumann HP, et al. Endoscopic treatment of solitary, bilateral, multiple, and recurrent pheochromocytomas and paragangliomas. World J Surg. 2002;26:1005-1012.
22. Brauckhoff M, Nguyen Thanh P, Bar A, Dralle H. Subtotal bilateral adrenalectomy preserving adrenocortical function [in German]. Chirurg. 2003;74:646-651.
23. Yip L, Lee JE, Shapiro SE, et al. Surgical management of hereditary pheochromocytoma. J Am Coll Surg. 2004;198:525-535.
24. Goldstein RE, O'Neill JA Jr, Holcomb GW, et al. Clinical experience over 48 years with pheochromocytoma. Ann Surg. 1999;229:755-764.
25. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: international RET mutation consortium analysis. JAMA. 1996;276:1575-1579.
26. Machens A, Brauckhoff M, Holzhausen HJ, Thanh PN, Lehnert H, Dralle H. Codon-specific development of pheochromocytoma in multiple endocrine neoplasia type 2. J Clin Endocrinol Metab. 2005;90:3999-4003.
27. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-5671.
28. Igaz P, Patocs A, Racz K, et al. Occurrence of pheochromocytoma in a MEN2A family with codon 609 mutation of the RET proto-oncogene. J Clin Endocrinol Metab. 2002;87:2994.
29. Jimenez C, Habra MA, Huang SC, et al. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation. J Clin Endocrinol Metab. 2004;89:4142-4145.
30. Brauckhoff M, Gimm O, Brauckhoff K, Dralle H. Repeat adrenocortical- sparing adrenalectomy for recurrent hereditary pheochromocytoma. Surg Today. 2004;34:251-255.
31. de Graaf JS, Lips CJ, Rutter JE, van Vroonhoven TJ. Subtotal adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2A. Eur J Surg. 1999;165:535-538.
32. Telenius-Berg M, Ponder MA, Berg B, Ponder BA, Werner S. Quality of life after bilateral adrenalectomy in MEN 2. Henry Ford Hosp Med J. 1989;37:160-163.